|
Apr 23 |
PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial...
Company to Host Key Opinion Leader Event on May... |
|
Mar 27 |
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results...
Unique mechanism of action of the combination of PDS01ADC... |
|
Mar 20 |
PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Results...
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- PDS... |
|
Mar 13 |
PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune...
Preclinical research published inVaccines... |
|
Jan 22 |
PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Off...
Board-certified oncologist and hematologist... |
|
Jan 16 |
PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference...
PRINCETON, N.J., Jan. 16, 2024 (GLOBE NEWSWIRE) -- PDS... |